Clinical Trials on Plaque Control

Total 37521 results

University of Alberta
Heart and Stroke Foundation of Canada

Not yet recruiting

Fish Oil, Metformin and Heart Health in PCOS

Cardiovascular Disease | PCOS | Cardiac Hypertrophy | Atherosclerotic Cardiovascular Disease | Atherosclerotic Plaque
Hoffmann-La Roche

Completed

A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease

Coronary Heart Disease

United States, Canada
Icahn School of Medicine at Mount Sinai
UCB Pharma; Psoriasis Treatment Center of Central New Jersey

Recruiting

Bimekizumab in Plaque Psoriasis

Plaque Psoriasis

United States
Bio-Thera Solutions

Recruiting

Clinical Study of Stage IV Psoriasis in Children With Geleli

Plaque Psoriasis

China
University of Pennsylvania

Recruiting

CT Evaluation of Carotid Plaque Components

Carotid Plaque

United States
Microbio Co Ltd

Not yet recruiting

Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Plaque Psoriasis

Plaque Psoriasis
Shanghai Yueyang Integrated Medicine Hospital
Shanghai Skin Disease and Venereal Disease Hospital

Not yet recruiting

Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine

Plaque Psoriasis
Mindera Health

Not yet recruiting

A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering From Plaque Psoriasis Through Clinical Utility and Health Outcomes. (MATCH)

Plaque Psoriasis
Pfizer

Terminated

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

Plaque Psoriasis

Canada, United States
Almirall, S.A.

Active, not recruiting

A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults (PRO-SCALP)

Plaque Psoriasis

Germany, Spain, United Kingdom
Meiji Pharma USA Inc.

Completed

Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

United States, Canada
Janssen Research & Development, LLC

Active, not recruiting

A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) (ICONIC-TOTAL)

Plaque Psoriasis

United States, Korea, Republic of, Hungary, United Kingdom, Germany, Poland, Turkey, Canada, Taiwan, Spain, Argentina
Galderma R&D

Active, not recruiting

A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

Psoriasis | Plaque Psoriasis

United States
Lander Enterprises, LLC

Completed

Plaque Removal Efficacy of a U-Shaped Sonic Power Toothbrush in Children

Dental Plaque

United States
Primus Pharmaceuticals
Prosoft Clinical

Completed

DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis (BDS1307)

Plaque Psoriasis

United States
Primus Pharmaceuticals
Prosoft Clinical

Completed

Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Janssen Research & Development, LLC

Active, not recruiting

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis (FRONTIER 2)

Plaque Psoriasis

United States, Korea, Republic of, Germany, France, Taiwan, Japan, Spain, United Kingdom, Poland, Canada
Bio-Thera Solutions

Completed

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

China
Arcutis Biotherapeutics, Inc.

Completed

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Psoriasis | Plaque Psoriasis

United States, Canada, Dominican Republic
Bioeq GmbH

Completed

A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis (VESPUCCI)

Plaque Psoriasis

Poland, Estonia, Ukraine, Georgia
UCB Biopharma SRL

Completed

A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice (CIMREAL)

Plaque Psoriasis

Belgium, Canada, Czechia, France, Germany, Greece, Italy, Spain, United Kingdom
Dermavant Sciences GmbH
IQVIA Biotech

Completed

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Plaque Psoriasis

United States, Canada
Durect
Therapeutics, Inc.

Completed

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Plaque Psoriasis

United States
Galderma R&D

Completed

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Plaque Psoriasis

United States
Galderma R&D

Completed

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Plaque Psoriasis

United States
Dermavant Sciences GmbH

Completed

Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis

Plaque Psoriasis

United States
Amgen

Completed

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis (ESTEEM 1)

Plaque Psoriasis
Pfizer

Completed

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

Plaque Psoriasis

Iraq
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis (MATURE)

Plaque Psoriasis

Spain, Germany, United States, Iceland, Canada, Poland
Yonsei University
National Research Foundation of Korea

Completed

Efficacy of Using 3D Motion Tracking Toothbrush in Dental Plaque Control

Toothbrushing
Bausch Health Americas, Inc.
Dow Pharmaceutical Sciences

Completed

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Eli Lilly and Company

Completed

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-R)

Plaque Psoriasis

United States, Puerto Rico, Canada
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Puerto Rico, United States, Germany, Poland, Japan, Canada
Amgen

Completed

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Plaque Psoriasis

United States
University of Florence

Completed

Efficacy of an U-shape Automatic Electric Toothbrush in Plaque Removal

Dental Plaque | Toothbrushing

Italy
Jiangsu HengRui Medicine Co., Ltd.

Suspended

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

Plaque Psoriasis

China
Therapeutics, Inc.

Completed

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

Plaque Psoriasis

United States
Bausch Health Americas, Inc.

Terminated

Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects (AMAGINE-3)

Plaque Psoriasis

United States, Belgium, Italy, Hungary, Poland, Australia, France, Greece, Russian Federation, Latvia, Canada
Akeso
Akeso Tiancheng, Inc

Completed

A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

China
Eli Lilly and Company

Completed

Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis (UNCOVER-A)

Plaque Psoriasis

United States, Puerto Rico
Novartis Pharmaceuticals

Completed

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis (CLARITY)

Plaque Psoriasis

United States, Hungary, Malaysia, Czechia, Korea, Republic of, Guatemala, Poland, Vietnam, Canada, Iceland, Slovakia
Santalis Pharmaceuticals, Inc.
Derm Research, PLLC; ClinDatrix, Inc.; Clinical Trials of Texas, Inc.; Progressive... and other collaborators

Completed

A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Derm Research, PLLC
Celgene

Completed

Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy

Plaque Psoriasis

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)

Plaque Psoriasis
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)

Psoriasis | Plaque Psoriasis

United States
Taro Pharmaceuticals USA

Completed

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Plaque Psoriasis
Therapeutics, Inc.

Completed

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

Plaque Psoriasis

United States
Therapeutics, Inc.

Completed

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis

Plaque Psoriasis

United States
AmDerma
International Dermatology Research, Inc.

Completed

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

Plaque Psoriasis

Dominican Republic
Wake Forest University
LEO Pharma

Completed

Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris (PSTaclonex)

Plaque Psoriasis

United States

3

Subscribe